MT. KISCO, N.Y., March 13, 2014 (GLOBE NEWSWIRE) -- IMMUDYNE, Inc. (OTCQB:IMMD) announced today that it has contracted with Who Has It? App to promote the Company's proprietary, anti-aging skincare line, NAYAD Rejuvenating Serum and Moisturizer.

Who Has It? has a growing subscriber list of over 50,000 consumers and has signed over 35 celebrities; including 49ers' quarterback Colin Kaepernick, Grammy nominee J. Holiday, and Real Housewife of Orange County, Gretchen Rossi. Who Has It? has partnered with over 50 brands, including Amazon, Athletes Brand, Creative Recreation, Passback Sports, and Young & Reckless.

Jennifer Colli, Founder and CEO of Who Has It? stated, "Who Has It? exclusively partners with the highest quality brands and products. I have personally used the NAYAD Rejuvenating serum and was very impressed with the quality of the product. I am excited to offer our celebrity clients the NAYAD skincare line and promote the product to our network reach of over 22 million users, which includes our celebrities' social media platforms."

Karen Kingston, Chief Marketing Officer, stated, "We believe that partnering with Jennifer Colli, her clients, and the Who Has It? App is a great platform to promote NAYAD's Rejuvenating skincare line. While NAYAD's proprietary active ingredients are found in some of the top-selling, elite, cosmeceutical lines, we are excited to now be able to directly reach celebrities and sell to consumers through this digital promotion with Who Has It?" 

NAYAD is a proprietary, topical formulation of beta-1,3/1,6-D-glucan that naturally activates topical and circulatory immune system cells. Topical beta-glucans have been proven to naturally increase cell renewal, collagen production, skin firmness, volume, and reduce fine lines, wrinkles, topical infections, and scars. In an 8-week clinical trial, participants who used NAYAD Rejuvenating Serum had a significant improvement in the appearance of their skin firmness and decreased appearance of wrinkles. Participants' skin appeared to look 15 years younger at the end of the trial. More information can be found at

About Who Has It?

Who Has It? is a brand new app that lets users peek into the day-to-day life of celebrities, musicians, and athletes to see what garments and brands they love! The Who Has It? app provides a mobile solution that's not just for fashion aficionados, but for anyone interested in staying on top of the products and brands that help define celebrity VIP images. Who Has It? eliminates the frustrating task of searching for the perfect thing, and provides one-stop shopping from your smartphone.

More information about the app can be found at

About Immudyne

IMMUDYNE manufactures and sells proprietary, clinically researched, doctor-recommended, yeast beta-1,3/1,6-D-glucan immune support supplements and topical skin care products. ImmuDyne has a portfolio of unique proprietary and patent-protected products with applications in the wellness, skin care, anti-aging, fitness, and health markets. Immudyne has offices located in Mt. Kisco, NY, Carlsbad, CA, and Florence, Kentucky. PURACERE, iNR Start, iNR Strength, iNR Wellness, and iNR Wellness MD are trademarks of ImmuDyne, Inc. 2013. Immudyne shares trade under the ticker symbol IMMD and the Company can be found on the web at

Cautionary language regarding Forward-Looking Statements Safe Harbor Act Disclaimer: Forward-looking statements in this release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Certain statements in this press release may contain words such as "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "projects," "plans," "targets" and other similar language and are considered forward-looking statements. These statements are based on management's current expectations, estimates, and forecasts. These forward-looking statements are subject to important assumptions, risks and uncertainties, which are difficult to predict and therefore the actual results may be materially different from those discussed.

Immudyne, Inc.
Mark McLaughlin